Nifty

:

25571.25

Sensex

:

82814.71

116.90 (0.46%)
316.57 (0.38%)

Login

Nifty
Sensex

:
:

25571.25
82814.71

116.90 (0.46%)
316.57 (0.38%)

Fermenta Biotech Ltd.

Miscellaneous

Rating :

69/99

BSE: 506414 | NSE: Not Listed

Watchlist

NSE BSE

323.25

20-Feb-2026

Open
High
Low
Previous Close

323.5
324.05
312.35
319.75

Volume
Traded Value (lacs)
52 Week High
52 Week Low

5835
1859240
324.05
0

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

951.36
10.84
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,006.37
0.77%
2.36

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

11.73
4.47
10.29

EBITDA CAGR (%)

10 Years
5 Years
3 Years

18.56
6.00
43.45

PAT CAGR (%)

10 Years
5 Years
3 Years

-
11.05
-

P:E (Median)

8 Years
5 Years
3 Years

10.54
10.24
-

P:BV (Average)

8 Years
5 Years
3 Years

2.71
2.15
2.24

EV:EBITDA (Average)

8 Years
5 Years
3 Years

13.95
17.00
19.31

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 114.24 146.25 -21.89% 107.12 89.54 19.63% 119.02 72.70 63.71% 122.04 89.66 36.11%
Expenses 90.78 96.11 -5.55% 84.15 74.05 13.64% 96.49 70.89 36.11% 89.36 80.73 10.69%
EBITDA 23.46 50.14 -53.21% 22.97 15.49 48.29% 22.53 1.81 1,144.75% 32.67 8.92 266.26%
EBIDTM 20.54% 34.28% 21.44% 17.30% 18.93% 2.49% 26.77% 9.95%
Other Income 3.43 2.22 54.50% 5.53 2.95 87.46% 8.84 2.63 236.12% 3.88 1.50 158.67%
Interest 3.03 4.09 -25.92% 2.59 3.69 -29.81% 3.10 3.42 -9.36% 2.99 3.42 -12.57%
Depreciation 5.17 5.82 -11.17% 5.13 5.89 -12.90% 5.55 5.87 -5.45% 5.60 6.20 -9.68%
PBT 16.59 42.45 -60.92% 20.77 8.86 134.42% 22.72 -4.85 - 27.97 0.81 3,353.09%
Tax 4.83 7.45 -35.17% 6.05 0.70 764.29% 6.48 0.00 0 -1.34 8.05 -
PAT 11.76 35.00 -66.40% 14.72 8.16 80.39% 16.23 -4.85 - 29.31 -7.25 -
PATM 10.29% 23.93% 13.74% 9.11% 13.64% -6.67% 24.02% -8.08%
EPS 4.00 11.90 -66.39% 5.01 2.77 80.87% 5.52 -1.65 - 9.97 -2.46 -

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 137.36 156.47 -12.21% 130.22 95.03 37.03% 136.26 78.13 74.40% 139.85 97.34 43.67%
Expenses 112.40 103.20 8.91% 103.59 76.25 35.86% 108.03 77.33 39.70% 102.90 91.97 11.88%
EBITDA 24.96 53.27 -53.14% 26.64 18.78 41.85% 28.23 0.80 3,428.75% 36.94 5.37 587.90%
EBIDTM 18.17% 34.05% 20.45% 19.76% 20.72% 1.03% 26.42% 5.52%
Other Income 3.12 2.23 39.91% 5.43 2.88 88.54% 8.77 2.82 210.99% 3.89 5.38 -27.70%
Interest 3.04 4.08 -25.49% 2.58 3.69 -30.08% 3.10 3.43 -9.62% 2.99 3.39 -11.80%
Depreciation 5.37 6.08 -11.68% 5.40 6.15 -12.20% 5.81 6.12 -5.07% 5.87 6.46 -9.13%
PBT 17.48 45.34 -61.45% 24.08 11.82 103.72% 28.09 -5.93 - 31.98 0.91 3,414.29%
Tax 5.46 7.45 -26.71% 6.05 0.70 764.29% 6.48 0.00 0 -1.34 8.05 -
PAT 12.02 37.89 -68.28% 18.03 11.12 62.14% 21.60 -5.93 - 33.32 -7.15 -
PATM 8.75% 24.21% 13.85% 11.70% 15.85% -7.59% 23.83% -7.34%
EPS 4.39 12.66 -65.32% 6.49 3.92 65.56% 7.49 -2.01 - 11.79 -2.40 -

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 462.42 430.53 307.09 328.91 387.96 372.82 300.51 404.67 12.51 5.52 6.13 Net Sales Growth 16.14% 40.20% -6.63% -15.22% 4.06% 24.06% -25.74% 3134.77% 126.63% -9.95% Cost Of Goods Sold 158.34 138.63 105.43 126.50 144.20 123.64 82.67 92.26 0.00 0.00 0.00 Gross Profit 304.08 291.90 201.66 202.42 243.77 249.18 217.83 312.42 12.51 5.52 6.13 GP Margin 65.76% 67.80% 65.67% 61.54% 62.83% 66.84% 72.49% 77.20% 100% 100% 100% Total Expenditure 360.78 330.76 269.76 289.93 311.25 278.20 231.94 276.88 23.78 14.06 12.79 Power & Fuel Cost - 27.23 19.78 18.24 20.35 14.23 12.74 13.88 2.47 1.54 0.80 % Of Sales - 6.32% 6.44% 5.55% 5.25% 3.82% 4.24% 3.43% 19.74% 27.90% 13.05% Employee Cost - 60.10 53.93 53.81 59.36 57.50 50.03 53.18 5.77 5.63 5.11 % Of Sales - 13.96% 17.56% 16.36% 15.30% 15.42% 16.65% 13.14% 46.12% 101.99% 83.36% Manufacturing Exp. - 40.92 33.48 31.59 34.43 29.83 21.52 27.60 3.13 1.96 1.07 % Of Sales - 9.50% 10.90% 9.60% 8.87% 8.00% 7.16% 6.82% 25.02% 35.51% 17.46% General & Admin Exp. - 41.28 41.36 41.26 35.60 26.90 32.84 27.69 2.83 3.80 3.71 % Of Sales - 9.59% 13.47% 12.54% 9.18% 7.22% 10.93% 6.84% 22.62% 68.84% 60.52% Selling & Distn. Exp. - 13.88 9.90 9.99 13.15 17.49 23.38 31.40 0.15 0.23 0.65 % Of Sales - 3.22% 3.22% 3.04% 3.39% 4.69% 7.78% 7.76% 1.20% 4.17% 10.60% Miscellaneous Exp. - 8.72 5.87 8.54 4.16 8.60 8.76 30.87 9.43 0.89 0.65 % Of Sales - 2.03% 1.91% 2.60% 1.07% 2.31% 2.92% 7.63% 75.38% 16.12% 23.82% EBITDA 101.63 99.77 37.33 38.98 76.71 94.62 68.57 127.79 -11.27 -8.54 -6.66 EBITDA Margin 21.98% 23.17% 12.16% 11.85% 19.77% 25.38% 22.82% 31.58% -90.09% -154.71% -108.65% Other Income 21.68 12.66 8.15 8.46 7.63 6.73 14.19 26.48 2.27 0.51 1.20 Interest 11.71 14.84 17.40 21.35 18.11 19.10 20.27 21.30 10.63 6.49 1.96 Depreciation 21.45 23.17 23.70 24.48 23.67 19.03 14.94 11.85 3.83 3.45 1.80 PBT 88.05 74.42 4.39 1.61 42.56 63.23 47.55 121.12 -23.46 -17.97 -9.21 Tax 16.02 6.80 14.14 -0.97 12.33 11.26 -16.12 10.77 0.69 0.33 -0.08 Tax Rate 18.19% 9.14% -306.72% 1.67% 28.97% 17.81% -33.90% 8.89% -2.94% -1.84% 0.87% PAT 72.02 67.62 -18.74 -57.00 30.24 51.97 63.67 110.35 -24.15 -18.30 -9.14 PAT before Minority Interest 72.02 67.62 -18.74 -57.00 30.24 51.97 63.67 110.35 -24.15 -18.30 -9.14 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 15.57% 15.71% -6.10% -17.33% 7.79% 13.94% 21.19% 27.27% -193.05% -331.52% -149.10% PAT Growth 131.87% - - - -41.81% -18.38% -42.30% - - - EPS 24.50 23.00 -6.37 -19.39 10.29 17.68 21.66 37.53 -8.21 -6.22 -3.11

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 543.69 469.48 335.66 349.94 398.52 377.29 292.95 404.67 302.67 164.13 154.80 Net Sales Growth 27.34% 39.87% -4.08% -12.19% 5.63% 28.79% -27.61% 33.70% 84.41% 6.03% Cost Of Goods Sold 195.35 147.40 130.13 153.55 153.15 134.37 79.02 92.26 80.41 68.43 64.51 Gross Profit 348.34 322.08 205.52 196.39 245.36 242.92 213.92 312.42 222.26 95.70 90.29 GP Margin 64.07% 68.60% 61.23% 56.12% 61.57% 64.39% 73.02% 77.20% 73.43% 58.31% 58.33% Total Expenditure 426.92 358.98 307.77 331.75 336.29 294.71 228.64 269.35 211.54 152.17 134.66 Power & Fuel Cost - 27.23 19.78 18.24 20.35 14.23 12.74 13.88 11.11 9.97 8.67 % Of Sales - 5.80% 5.89% 5.21% 5.11% 3.77% 4.35% 3.43% 3.67% 6.07% 5.60% Employee Cost - 65.10 58.55 58.00 62.97 58.22 50.03 53.18 39.83 30.84 27.97 % Of Sales - 13.87% 17.44% 16.57% 15.80% 15.43% 17.08% 13.14% 13.16% 18.79% 18.07% Manufacturing Exp. - 46.62 36.56 32.66 37.22 31.08 21.62 27.60 26.64 17.04 12.03 % Of Sales - 9.93% 10.89% 9.33% 9.34% 8.24% 7.38% 6.82% 8.80% 10.38% 7.77% General & Admin Exp. - 46.78 46.09 46.09 39.95 29.05 33.12 27.57 15.80 13.19 12.46 % Of Sales - 9.96% 13.73% 13.17% 10.02% 7.70% 11.31% 6.81% 5.22% 8.04% 8.05% Selling & Distn. Exp. - 17.47 11.36 13.97 17.06 19.13 23.38 31.40 26.90 5.47 5.71 % Of Sales - 3.72% 3.38% 3.99% 4.28% 5.07% 7.98% 7.76% 8.89% 3.33% 3.69% Miscellaneous Exp. - 8.37 5.30 9.24 5.58 8.63 8.73 23.47 10.84 7.23 5.71 % Of Sales - 1.78% 1.58% 2.64% 1.40% 2.29% 2.98% 5.80% 3.58% 4.41% 2.13% EBITDA 116.77 110.50 27.89 18.19 62.23 82.58 64.31 135.32 91.13 11.96 20.14 EBITDA Margin 21.48% 23.54% 8.31% 5.20% 15.62% 21.89% 21.95% 33.44% 30.11% 7.29% 13.01% Other Income 21.21 11.82 11.81 8.60 8.25 8.37 14.20 26.50 10.83 2.78 1.31 Interest 11.71 14.89 17.43 21.37 17.98 19.00 20.09 21.23 13.63 9.96 6.15 Depreciation 22.45 24.22 24.72 28.25 25.56 20.31 15.00 11.89 12.36 10.31 8.35 PBT 101.63 83.21 -2.45 -22.83 26.94 51.63 43.42 128.71 75.97 -5.53 6.96 Tax 16.65 6.80 14.14 1.83 11.88 9.10 -16.10 10.80 21.13 2.70 4.25 Tax Rate 16.38% 8.17% -143.12% -3.57% 44.10% 17.63% -37.08% 8.39% 27.81% -48.82% 61.06% PAT 84.97 76.86 -23.06 -51.07 15.45 45.51 59.53 117.88 42.21 -11.03 -0.59 PAT before Minority Interest 87.78 76.40 -24.01 -53.13 15.06 42.53 59.52 117.90 54.84 -8.23 2.71 Minority Interest 2.81 0.46 0.95 2.06 0.39 2.98 0.01 -0.02 -12.63 -2.80 -3.30 PAT Margin 15.63% 16.37% -6.87% -14.59% 3.88% 12.06% 20.32% 29.13% 13.95% -6.72% -0.38% PAT Growth 136.49% - - - -66.05% -23.55% -49.50% 179.27% - - EPS 28.90 26.14 -7.84 -17.37 5.26 15.48 20.25 40.10 14.36 -3.75 -0.20

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 379.95 314.23 336.06 395.97 370.45 312.60 249.49 64.72 89.61 82.64 Share Capital 14.58 14.44 14.43 14.42 14.42 14.42 4.59 2.29 2.29 2.29 Total Reserves 365.07 287.05 308.38 366.86 344.03 292.10 244.15 62.43 87.31 80.35 Non-Current Liabilities 29.24 77.08 97.34 158.41 135.31 73.40 125.39 139.79 37.53 15.20 Secured Loans 15.05 42.59 83.54 114.68 110.44 101.79 135.21 132.02 34.26 14.15 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 21.61 14.97 20.08 67.33 58.67 4.06 6.31 0.72 0.75 0.35 Current Liabilities 231.75 181.70 233.34 207.38 213.58 185.51 156.78 18.09 18.49 51.66 Trade Payables 64.28 53.03 51.91 45.57 45.70 47.17 43.44 1.80 0.76 1.37 Other Current Liabilities 47.77 39.58 58.34 42.52 49.78 33.13 47.43 10.41 14.09 46.99 Short Term Borrowings 81.24 67.34 101.46 97.47 96.30 104.33 60.21 5.72 3.50 2.44 Short Term Provisions 38.46 21.75 21.63 21.82 21.79 0.88 5.70 0.16 0.13 0.85 Total Liabilities 640.94 573.01 666.74 761.76 719.34 571.51 531.66 222.60 145.63 149.50 Net Block 222.65 261.40 228.11 219.98 249.57 126.07 103.65 11.80 8.17 93.40 Gross Block 357.65 377.09 319.93 293.38 315.01 162.59 127.89 13.46 8.83 99.69 Accumulated Depreciation 135.00 115.70 91.82 73.40 65.44 36.52 24.24 1.66 0.66 6.19 Non Current Assets 287.11 313.97 392.69 425.79 390.64 289.06 226.21 217.51 136.80 136.52 Capital Work in Progress 15.91 1.62 45.02 34.57 56.91 70.77 21.58 0.00 1.30 0.58 Non Current Investment 3.69 3.63 12.57 12.99 12.95 71.86 74.58 107.40 29.76 39.86 Long Term Loans & Adv. 39.58 39.85 54.28 87.66 70.36 18.87 17.36 2.58 1.83 2.68 Other Non Current Assets 2.10 2.07 24.01 3.82 0.86 1.49 9.04 11.64 10.26 0.00 Current Assets 353.84 259.04 274.04 335.97 328.69 282.46 295.26 5.09 8.82 12.98 Current Investments 0.00 0.00 2.78 0.00 0.00 0.00 1.15 1.06 1.00 0.80 Inventories 94.48 78.61 109.75 129.58 132.79 113.54 87.67 0.00 0.00 0.00 Sundry Debtors 120.21 77.13 67.41 117.83 96.12 77.44 65.60 0.28 0.39 0.03 Cash & Bank 61.95 56.64 55.11 30.75 41.30 32.37 90.73 1.57 0.96 3.00 Other Current Assets 77.20 7.92 4.12 15.65 58.47 59.10 50.12 2.18 6.47 9.15 Short Term Loans & Adv. 59.50 38.75 34.87 42.17 41.48 43.40 31.13 0.70 6.02 6.66 Net Current Assets 122.09 77.34 40.70 128.59 115.11 96.95 138.48 -13.00 -9.66 -38.68 Total Assets 640.95 573.01 666.73 761.76 719.33 571.52 531.66 222.60 145.62 149.50

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 362.67 288.86 315.31 372.13 360.59 309.44 250.55 124.45 144.40 129.82 Share Capital 14.58 14.44 14.43 14.42 14.42 14.42 4.59 2.29 2.29 2.29 Total Reserves 347.79 261.69 287.63 343.02 334.17 288.94 245.21 122.16 142.11 127.53 Non-Current Liabilities 29.24 77.03 97.43 154.05 131.41 71.52 125.39 145.65 48.11 24.27 Secured Loans 15.05 42.54 83.59 114.68 110.44 101.79 135.21 135.37 40.32 17.78 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 21.61 14.97 20.08 67.43 58.77 4.06 6.31 2.73 2.67 1.79 Current Liabilities 245.20 194.07 229.77 227.85 230.09 194.60 155.98 103.56 86.16 108.48 Trade Payables 77.49 64.90 45.79 64.58 62.14 56.33 42.72 40.09 27.49 19.77 Other Current Liabilities 47.84 39.61 58.53 43.72 49.90 33.12 47.42 29.38 20.79 56.62 Short Term Borrowings 81.24 67.34 101.46 97.47 96.30 104.33 60.21 29.86 37.13 29.34 Short Term Provisions 38.63 22.22 23.98 22.07 21.75 0.81 5.63 4.23 0.75 2.75 Total Liabilities 632.95 556.26 639.76 753.35 721.79 575.57 531.94 384.64 307.14 288.24 Net Block 223.37 263.13 238.25 231.31 262.93 128.89 103.73 96.88 89.81 168.10 Gross Block 367.61 387.06 338.52 308.92 330.73 166.48 128.99 114.18 103.03 221.97 Accumulated Depreciation 144.25 123.93 100.27 77.61 67.80 37.59 25.25 17.30 13.21 53.77 Non Current Assets 264.40 293.70 365.69 418.61 391.42 291.56 226.13 202.38 202.88 194.84 Capital Work in Progress 15.91 1.62 45.02 34.56 56.91 70.77 21.58 3.50 5.49 5.94 Non Current Investment 0.49 0.43 0.37 0.29 0.25 71.52 74.41 1.32 7.93 14.60 Long Term Loans & Adv. 19.36 21.05 29.33 81.35 70.47 19.60 18.64 6.80 4.51 6.20 Other Non Current Assets 2.10 2.07 24.01 3.82 0.86 0.78 7.77 13.39 13.31 0.01 Current Assets 368.55 262.57 274.07 334.74 330.38 284.01 295.61 182.27 104.26 93.40 Current Investments 0.00 0.00 2.78 0.00 0.00 0.00 1.15 1.06 1.00 0.80 Inventories 123.65 87.38 130.14 159.48 162.27 128.58 87.67 51.18 38.91 27.97 Sundry Debtors 95.23 69.83 41.65 87.09 68.01 69.77 65.54 68.72 44.57 43.01 Cash & Bank 71.70 59.83 58.33 33.61 44.53 33.11 91.13 32.66 2.49 4.79 Other Current Assets 77.98 6.55 4.08 11.25 55.56 52.55 50.12 28.65 17.28 16.84 Short Term Loans & Adv. 59.93 38.97 37.09 43.32 42.69 43.41 31.14 18.31 12.90 10.22 Net Current Assets 123.36 68.49 44.30 106.90 100.29 89.42 139.63 78.71 18.10 -15.08 Total Assets 632.95 556.27 639.76 753.35 721.80 575.57 531.93 384.65 307.14 288.24

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 33.83 105.02 123.75 50.41 62.96 29.83 90.51 1.32 -9.13 -4.97 PBT 74.42 -4.61 -57.98 42.56 63.23 47.55 121.12 -23.46 -17.97 -9.21 Adjustment 40.32 85.43 146.85 38.95 40.23 34.25 38.52 20.40 9.60 4.39 Changes in Working Capital -78.14 23.18 30.53 -21.83 -27.01 -38.05 -36.32 5.09 -2.10 0.67 Cash after chg. in Working capital 36.60 104.00 119.40 59.69 76.44 43.75 123.32 2.02 -10.47 -4.16 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -2.77 1.02 4.35 -9.28 -13.49 -13.91 -32.82 -0.70 1.35 -0.81 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 0.41 -15.15 -63.53 -32.46 -43.61 -39.19 -96.58 -88.99 19.64 -7.88 Net Fixed Assets 5.15 -13.76 -37.00 43.97 -138.56 -83.89 -136.01 -3.33 90.14 -15.75 Net Investments -0.06 11.72 -2.36 -0.04 58.91 3.87 32.73 -77.70 9.90 -0.61 Others -4.68 -13.11 -24.17 -76.39 36.04 40.83 6.70 -7.96 -80.40 8.48 Cash from Financing Activity -50.91 -90.86 -41.25 -21.76 -1.32 -47.63 12.22 88.31 -12.53 13.65 Net Cash Inflow / Outflow -16.67 -0.98 18.97 -3.81 18.03 -56.99 6.15 0.64 -2.01 0.80 Opening Cash & Equivalents 13.56 14.54 -4.49 -0.94 -18.96 38.02 31.87 0.71 2.72 2.19 Closing Cash & Equivalent -3.12 13.56 14.54 -4.75 -0.94 -18.96 38.02 1.35 0.71 3.00

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 40.90 105.35 116.11 43.44 62.60 34.46 90.34 59.26 1.91 4.44 PBT 83.21 -9.87 -51.31 26.94 51.63 43.42 128.71 75.97 -5.53 6.96 Adjustment 42.97 81.50 119.25 43.18 39.61 34.01 31.05 27.02 24.10 14.71 Changes in Working Capital -82.50 32.70 44.95 -17.38 -15.12 -29.03 -36.56 -25.46 -14.42 -14.47 Cash after chg. in Working capital 43.67 104.33 112.90 52.75 76.12 48.40 123.20 77.54 4.16 7.21 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -2.77 1.02 3.21 -9.31 -13.52 -13.94 -32.86 -18.28 -2.25 -2.77 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -0.16 -15.50 -55.41 -26.04 -41.55 -43.66 -96.58 -101.14 6.52 -13.38 Net Fixed Assets 5.15 -13.76 -37.00 43.97 -138.56 -83.89 -136.01 -3.33 90.14 -15.75 Net Investments -0.06 11.72 -2.36 -0.04 58.91 3.87 32.73 -77.70 9.90 -0.61 Others -5.25 -13.46 -16.05 -69.97 38.10 36.36 6.70 -20.11 -93.52 2.98 Cash from Financing Activity -50.87 -90.85 -41.38 -21.58 -1.14 -47.45 12.22 88.82 -12.11 10.42 Net Cash Inflow / Outflow -10.12 -1.00 19.32 -4.17 19.90 -56.65 5.99 46.93 -3.67 1.48 Opening Cash & Equivalents 16.75 17.75 -1.61 2.29 -18.22 38.42 32.44 -14.50 -10.82 3.30 Closing Cash & Equivalent 6.63 16.75 17.75 -1.88 2.29 -18.22 38.42 32.44 -14.50 4.79

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 130.16 104.42 111.86 132.17 124.26 106.26 86.69 23.52 32.56 30.03 ROA 11.14% -3.02% -7.98% 4.08% 8.05% 11.54% 29.26% -13.12% -12.40% -6.24% ROE 19.85% -6.00% -16.19% 8.18% 15.63% 23.36% 72.78% -31.30% -21.25% -10.44% ROCE 19.07% 2.56% -6.18% 9.85% 14.54% 13.83% 43.46% -7.52% -8.47% -5.46% Fixed Asset Turnover 1.17 0.88 1.07 1.28 1.56 2.07 5.73 1.12 0.10 0.10 Receivable days 83.65 85.90 102.78 100.64 84.96 86.87 29.71 9.76 13.86 5.98 Inventory Days 73.37 111.94 132.79 123.42 120.58 122.20 79.07 0.00 0.00 0.00 Payable days 154.43 181.65 140.63 115.51 137.08 79.96 34.73 30.19 30.05 43.28 Cash Conversion Cycle 2.59 16.19 94.95 108.55 68.46 129.11 74.05 -20.43 -16.19 -37.30 Total Debt/Equity 0.29 0.44 0.67 0.62 0.64 0.72 0.87 2.21 0.49 0.66 Interest Cover 6.02 0.74 -1.72 3.35 4.31 3.35 6.69 -1.21 -1.77 -3.71

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 124.23 95.63 104.67 123.91 120.84 105.16 87.07 45.22 52.47 47.18 ROA 12.85% -4.01% -7.63% 2.04% 6.56% 10.75% 25.73% 15.85% -2.76% 0.99% ROE 23.93% -8.30% -16.11% 4.27% 13.05% 21.92% 64.77% 40.79% -6.00% 2.08% ROCE 21.97% 1.58% -5.25% 7.50% 12.62% 12.98% 40.16% 33.86% 1.96% 6.18% Fixed Asset Turnover 1.24 0.93 1.08 1.25 1.52 1.98 3.33 2.79 1.02 0.87 Receivable days 64.16 60.61 67.14 71.03 66.65 84.30 60.55 68.24 96.46 90.86 Inventory Days 82.04 118.27 151.04 147.34 140.69 134.72 62.62 54.27 73.67 57.38 Payable days 176.30 155.24 131.18 150.99 160.90 86.23 63.57 60.55 60.91 51.44 Cash Conversion Cycle -30.10 23.64 87.00 67.38 46.44 132.79 59.60 61.95 109.22 96.80 Total Debt/Equity 0.30 0.48 0.72 0.66 0.66 0.73 0.87 1.39 0.60 0.70 Interest Cover 6.59 0.43 -1.40 2.50 3.72 3.16 7.06 6.57 0.45 2.13

Top Investors:

rakesh kantilal shah

krishan premnarayen .

fermenta biotech limited esop trust

investor education and protection fund (iepf)

Annual Reports:

News Update:

Fermenta Biotech - Quarterly Results
10th Feb 2026, 00:00 AM

Read More
Fermenta Biotech gets nod to raise Rs 150 crore
10th Dec 2025, 15:43 PM

The Board of Directors of the Company, at its meeting held on December 10, 2025, has, inter alia, considered and approved the same
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback